Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 30/Signature 2
From BugSigDB
Needs review
Source: Additional file 12: Figure S12
Description: Differentially abundant taxa between the VANM group and HRZ (H-Isoniazid, R-Rifampin, Z-Pyrazinamide) treatment group.
Abundance in Group 1: decreased abundance in HRZ(H-Isoniazid, R-Rifampin, Z-Pyrazinamide)
| NCBI | Quality Control | Links |
|---|---|---|
| Parabacteroides | ||
| Brenneria | ||
| Ruminiclostridium | ||
| Lactobacillus | ||
| Eubacteriales Family XIII. Incertae Sedis |
Revision editor(s): KateRasheed
